The post How Polymarket and Kalshi Are Turning Bets Into Billions appeared on BitcoinEthereumNews.com. Fintech The idea that people can trade on the future – from elections to sports scores – has officially gone mainstream. Two of the world’s biggest prediction platforms, Polymarket and Kalshi, just proved it by pulling in multi-billion-dollar backing and rewriting what the next generation of speculation looks like. The Numbers Behind the Mania The surge began when Intercontinental Exchange (ICE), parent of the New York Stock Exchange, quietly led a $2 billion investment into Polymarket, valuing it at a staggering $9 billion. Days later, Kalshi announced a $300 million raise that pushed its own valuation to $5 billion – signaling a market segment no longer confined to crypto’s fringes. Polymarket’s founder, Shayne Coplan, became one of the youngest billionaires in fintech history after the raise – a symbol of just how fast the industry has evolved since the first blockchain-based betting markets appeared a few years ago. Two Paths, One Destination While the companies share the same goal – turning opinions into tradable assets – their philosophies couldn’t be more different. Kalshi operates entirely within the U.S. regulatory perimeter, offering markets through a traditional clearinghouse model that appeals to retail traders on platforms like Robinhood, which recently integrated Kalshi’s markets into its app. Polymarket, in contrast, remains rooted in crypto, running fully onchain where every market and position can be audited on the blockchain. Transparency and decentralization are its calling cards. Their rivalry has quietly become one of the most intriguing duels in financial tech. Kalshi recently flipped the leaderboard, grabbing about 60% of total trading share in September. Yet both platforms hit record volumes, generating more than $1.4 billion in combined activity – proof that the prediction market sector is expanding fast enough for both to win. Speculation Goes Mainstream Once dismissed as internet novelty, prediction markets are… The post How Polymarket and Kalshi Are Turning Bets Into Billions appeared on BitcoinEthereumNews.com. Fintech The idea that people can trade on the future – from elections to sports scores – has officially gone mainstream. Two of the world’s biggest prediction platforms, Polymarket and Kalshi, just proved it by pulling in multi-billion-dollar backing and rewriting what the next generation of speculation looks like. The Numbers Behind the Mania The surge began when Intercontinental Exchange (ICE), parent of the New York Stock Exchange, quietly led a $2 billion investment into Polymarket, valuing it at a staggering $9 billion. Days later, Kalshi announced a $300 million raise that pushed its own valuation to $5 billion – signaling a market segment no longer confined to crypto’s fringes. Polymarket’s founder, Shayne Coplan, became one of the youngest billionaires in fintech history after the raise – a symbol of just how fast the industry has evolved since the first blockchain-based betting markets appeared a few years ago. Two Paths, One Destination While the companies share the same goal – turning opinions into tradable assets – their philosophies couldn’t be more different. Kalshi operates entirely within the U.S. regulatory perimeter, offering markets through a traditional clearinghouse model that appeals to retail traders on platforms like Robinhood, which recently integrated Kalshi’s markets into its app. Polymarket, in contrast, remains rooted in crypto, running fully onchain where every market and position can be audited on the blockchain. Transparency and decentralization are its calling cards. Their rivalry has quietly become one of the most intriguing duels in financial tech. Kalshi recently flipped the leaderboard, grabbing about 60% of total trading share in September. Yet both platforms hit record volumes, generating more than $1.4 billion in combined activity – proof that the prediction market sector is expanding fast enough for both to win. Speculation Goes Mainstream Once dismissed as internet novelty, prediction markets are…

How Polymarket and Kalshi Are Turning Bets Into Billions

Fintech

The idea that people can trade on the future – from elections to sports scores – has officially gone mainstream.

Two of the world’s biggest prediction platforms, Polymarket and Kalshi, just proved it by pulling in multi-billion-dollar backing and rewriting what the next generation of speculation looks like.

The Numbers Behind the Mania

The surge began when Intercontinental Exchange (ICE), parent of the New York Stock Exchange, quietly led a $2 billion investment into Polymarket, valuing it at a staggering $9 billion. Days later, Kalshi announced a $300 million raise that pushed its own valuation to $5 billion – signaling a market segment no longer confined to crypto’s fringes.

Polymarket’s founder, Shayne Coplan, became one of the youngest billionaires in fintech history after the raise – a symbol of just how fast the industry has evolved since the first blockchain-based betting markets appeared a few years ago.

Two Paths, One Destination

While the companies share the same goal – turning opinions into tradable assets – their philosophies couldn’t be more different.

Kalshi operates entirely within the U.S. regulatory perimeter, offering markets through a traditional clearinghouse model that appeals to retail traders on platforms like Robinhood, which recently integrated Kalshi’s markets into its app.

Polymarket, in contrast, remains rooted in crypto, running fully onchain where every market and position can be audited on the blockchain. Transparency and decentralization are its calling cards.

Their rivalry has quietly become one of the most intriguing duels in financial tech. Kalshi recently flipped the leaderboard, grabbing about 60% of total trading share in September. Yet both platforms hit record volumes, generating more than $1.4 billion in combined activity – proof that the prediction market sector is expanding fast enough for both to win.

Speculation Goes Mainstream

Once dismissed as internet novelty, prediction markets are now bleeding into regulated finance. Kalshi’s link-up with Robinhood gives tens of millions of retail investors access to event contracts, while Polymarket’s blockchain model appeals to a new wave of crypto traders who value transparency over bureaucracy.

What started as a bet on the future has become a statement about the present: speculation isn’t just a corner of crypto anymore – it’s becoming a pillar of how the financial world measures belief, uncertainty, and risk.


The information provided in this article is for educational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Author

Kosta joined the team in 2021 and quickly established himself with his thirst for knowledge, incredible dedication, and analytical thinking. He not only covers a wide range of current topics, but also writes excellent reviews, PR articles, and educational materials. His articles are also quoted by other news agencies.



Next article

Source: https://coindoo.com/prediction-market-boom-how-polymarket-and-kalshi-are-turning-bets-into-billions/

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26